Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From bench to bedside: the history and progress of CAR T cell therapy
Aroshi Mitra, Amrita Barua, Luping Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 191

Showing 1-25 of 191 citing articles:

Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
Qing Li, Shan Geng, Hao Luo, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 57
Spleen SORT LNP Generated in situ CAR T Cells Extend Survival in a Mouse Model of Lymphoreplete B Cell Lymphoma
Ester Álvarez‐Benedicto, Zeru Tian, Sumanta Chatterjee, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 44
Open Access | Times Cited: 50
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 10, pp. 1089-1108
Open Access | Times Cited: 38
Translating B cell immunology to the treatment of antibody-mediated allograft rejection
Peter S. Heeger, Maria Carrera Haro, Stanley C. Jordan
Nature Reviews Nephrology (2024) Vol. 20, Iss. 4, pp. 218-232
Closed Access | Times Cited: 28
Colorectal cancer: Recent advances in management and treatment
Hiba Fadlallah, Jad El Masri, Hiam Fakhereddine, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 9, pp. 1136-1156
Open Access | Times Cited: 22
Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?
Caroline Lonez, Eytan Breman
Cells (2024) Vol. 13, Iss. 2, pp. 146-146
Open Access | Times Cited: 21
Emerging roles of CAR-NK cell therapies in tumor immunotherapy: current status and future directions
Yan Zhong, Jingfeng Liu
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 19
Characterization of second primary malignancies post CAR T-cell therapy: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase
Junyi Shen, Rong Hu, Anqi Lin, et al.
EClinicalMedicine (2024) Vol. 73, pp. 102684-102684
Open Access | Times Cited: 18
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 16
Tumor-induced metabolic immunosuppression: Mechanisms and therapeutic targets
Jean‐Ehrland Ricci
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115206-115206
Closed Access | Times Cited: 4
Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy
Fatemeh Dehghan, Yekta Metanat, Mandana Askarizadeh, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 3
Exploring Immune Checkpoint Inhibitors: Focus on PD-1/PD-L1 Axis and Beyond
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access | Times Cited: 2
CAR-T cell therapy for hematological malignancies: History, status and promise
Chao Wang, Jianpeng Wang, Shusheng Che, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21776-e21776
Open Access | Times Cited: 26
Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination
Zhaokai Zhou, Yumiao Mai, Ge Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217079-217079
Closed Access | Times Cited: 17
A landscape of checkpoint blockade resistance in cancer: underlying mechanisms and current strategies to overcome resistance
Ginette S. Santiago-Sánchez, Kellsye P. Fabian, James W. Hodge
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 16
Potential and pitfalls of repurposing the CAR-T cell regimen for the treatment of autoimmune disease
Andrea R. Daamen, Peter E. Lipsky
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 6, pp. 696-699
Closed Access | Times Cited: 14
Expanding CAR-T cell immunotherapy horizons through microfluidics
Hyelee Kim, Suyeon Kim, Hyunjung Lim, et al.
Lab on a Chip (2024) Vol. 24, Iss. 5, pp. 1088-1120
Open Access | Times Cited: 13
The next frontier in immunotherapy: potential and challenges of CAR-macrophages
Jing Li, Ping Chen, Wenxue Ma
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Update on Thrombosis Risk in Patients with Cancer: Focus on Novel Anticancer Immunotherapies
Florian Moik, Jakob M. Riedl, Cornelia Englisch, et al.
Hämostaseologie (2024) Vol. 44, Iss. 01, pp. 040-048
Open Access | Times Cited: 11
A high-density microfluidic bioreactor for the automated manufacturing of CAR T cells
Wei‐Xiang Sin, N. Suhas Jagannathan, Denise Bei Lin Teo, et al.
Nature Biomedical Engineering (2024)
Closed Access | Times Cited: 11
Optimizing mesenchymal stem cell extracellular vesicles for chronic wound healing: Bioengineering, standardization, and safety
Yusuke Shimizu, Edward Hosea Ntege, Yoshikazu Inoue, et al.
Regenerative Therapy (2024) Vol. 26, pp. 260-274
Open Access | Times Cited: 10
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 10
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks
Caroline Diorio, David T. Teachey, Stephan A. Grupp
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 10
Role of FDG PET/CT in Patients With Lymphoma Treated With Chimeric Antigen Receptor T-Cell Therapy: Current Concepts
Vanessa Murad, Andrés Kohan, Claudia Ortega, et al.
American Journal of Roentgenology (2024) Vol. 222, Iss. 3
Open Access | Times Cited: 9
ReCARving the future: bridging CAR T-cell therapy gaps with synthetic biology, engineering, and economic insights
Alaa M. Ali, John F. DiPersio
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top